Skip to content

Expiring federal contract

HHSO100201700020C — Regeneron Pharmaceuticals INC

Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response

Contract / PIID
HHSO100201700020C
Incumbent
Regeneron Pharmaceuticals INC
Incumbent UEI
N3F9MH7E6HD6
Current end date
September 25, 2027
Potential total value
$278,844,172
Obligated
$278,844,172
NAICS
541711 — Research and Development in Biotechnology
PSC
AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Set-aside
Full & Open
Start date
September 21, 2017
Place of performance
NY
Award type
DEFINITIVE CONTRACT

Source: USASpending.gov award record, last checked November 18, 2026. Place of performance as reported by USASpending.

What the contract covers

IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD

Likely rebid window (estimate)

  • Sources Sought / RFI: about Sep 2026 – Mar 2027 (6–12 months before the end date)
  • RFP: about May 2027 – Jul 2027 (2–4 months before the end date)

Now inside the estimated Sources Sought / RFI window.

Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.

Track this recompete free

  • Change history: 2 recorded changes to the end date, value or incumbent. Sign up to see each one.
  • Alerts: get an email when the end date moves or the follow-on is posted.
  • Contacts: the buying office and small-business contacts for this agency.

Other contracts expiring at Department of Health and Human Services (NAICS 541711)